Li-Fraumeni syndrome heterogeneity

被引：24

作者：

Gargallo, P. ^{[1
]}

Yanez, Y. ^{[2
]}

Segura, V. ^{[2
]}

Juan, A. ^{[1
]}

Torres, B. ^{[1
]}

Balaguer, J. ^{[1
]}

Oltra, S. ^{[3
,4
]}

Castel, V. ^{[1
]}

Canete, A. ^{[1
]}

机构：

[1] La Fe Hosp, Pediat Oncol, Av Fernando Abril Martorell 106, Valencia 46026, Spain

[2] La Fe Hosp, Clin & Translat Oncol Res Grp, Valencia, Spain

[3] La Fe Hosp, Genet Unit, Valencia, Spain

[4] Univ Valencia, Genet Dept, Valencia, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2020年 / 22卷 / 07期

关键词：

Li-Fraumeni syndrome; Genotype; Phenotype; Epigenome; Pediatrics; TP53 MUTATION CARRIERS; GAIN-OF-FUNCTION; CANCER PREDISPOSITION; MUTANT P53; RELATIVE FREQUENCY; TELOMERE LENGTH; WIDE SPECTRUM; TUMOR ONSET; GERMLINE; FAMILIES;

D O I：

10.1007/s12094-019-02236-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clinical variability is commonly seen in Li-Fraumeni syndrome. Phenotypic heterogeneity is present among different families affected by the same pathogenic variant in TP53 gene and among members of the same family. However, causes of this huge clinical spectrum have not been studied in depth. TP53 type mutation, polymorphic variants in TP53 gene or in TP53-related genes, copy number variations in particular regions, and/or epigenetic deregulation of TP53 expression might be responsible for clinical heterogeneity. In this review, recent advances in the understanding of genetic and epigenetic aspects influencing Li-Fraumeni phenotype are discussed.

引用

页码：978 / 988

页数：11

共 50 条

[31] Li-Fraumeni syndrome - A molecular and clinical review
Varley, JM
Evans, DGR
Birch, JM
BRITISH JOURNAL OF CANCER, 1997, 76 (01) : 1 - 14
[32] P53 AND THE LI-FRAUMENI SYNDROME
MALKIN, D
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 197 - 213
[33] Cancer surveillance for individuals with Li-Fraumeni syndrome
Kratz, Christian P.
Villani, Anita
Nichols, Kim E.
Schiffman, Joshua
Malkin, David
EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (11) : 1481 - 1482
[34] The 2016 Li-Fraumeni syndrome cancer spectrum
Caron, Olivier
Frebourg, Thierry
Benusiglio, Patrick R.
Faivre, Laurence
Dugast, Catherine
Bonadona, Valerie
Coupier, Isabelle
Maugard, Christine M.
Pujol, Pascal
Barouk-Simonet, Emmanuelle
Delnatte, Capucine
Bignon, Yves-Jean
Eisinger, Francois
Chabbert-Buffet, Nathalie
Canale, Sandra
Fasse, Leonor
Foulon, Stephanie
Brugieres, Laurence
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[35] Biochemical and imaging surveillance in Li-Fraumeni syndrome
Raskind, Wendy H.
Hisama, Fuki M.
Bennett, Robin L.
LANCET ONCOLOGY, 2016, 17 (11): : E472 - E472
[36] Spitzoid Melanoma in a Child with Li-Fraumeni Syndrome
Kollipara, Ramya
Cooley, Linda D.
Horii, Kimberly A.
Hetherington, Maxine L.
Leboit, Philip E.
Singh, Vivekanand
Zwick, David L.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2014, 17 (01) : 64 - 69
[37] Characterization of sarcoma topography in Li-Fraumeni syndrome
Brockman, Karin J.
Thompson, Mone't B.
Mirabello, Lisa
Savage, Sharon A.
Malayeri, Ashkan
Hatton, Jessica N.
Khincha, Payal P.
FRONTIERS IN ONCOLOGY, 2024, 14
[38] Increased Oxidative Metabolism in the Li-Fraumeni Syndrome
Wang, Ping-yuan
Ma, Wenzhe
Park, Joon-Young
Celi, Francesco S.
Arena, Ross
Choi, Jeong W.
Ali, Qais A.
Tripodi, Dotti J.
Zhuang, Jie
Lago, Cory U.
Strong, Louise C.
Talagala, S. Lalith
Balaban, Robert S.
Kang, Ju-Gyeong
Hwang, Paul M.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11): : 1027 - 1032
[39] P53 AND THE LI-FRAUMENI SYNDROME
MALKIN, D
CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 83 - 92
[40] Genetic modeling of Li-Fraumeni syndrome in zebrafish
Parant, John M.
George, Stephen A.
Holden, Joseph A.
Yost, H. Joseph
DISEASE MODELS & MECHANISMS, 2010, 3 (1-2) : 45 - 56

← 1 2 3 4 5 →